statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KR Choksey is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 503 in its research report dated April 29, 2024.

Buy Laurus Labs; target of Rs 503: KR Choksey

Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 480 in its research report dated April 25, 2024.

Buy Laurus Labs; target of Rs 480: Motilal Oswal

Laurus Labs' net profit fell 25 percent to Rs 76 crore, while revenue rose 4 percent to Rs 1,439.67 crore

Laurus Labs shares erase intraday losses to swing into green, Motilal Oswal sees 13% upside

In FY24, CDMO sales declined 57% YoY to Rs 9.2 billion

Laurus Labs: CDMO services key to improved prospects, say analysts

Laurus Labs Q4 earnings: A poll of brokerages had pegged the profit at Rs 107 crore

Laurus Labs Q4 results: Net profit drops 25% to Rs 76 crore, revenue up 4%

Brokerage Goldman Sachs has initiated buy ratings on Syngene International Ltd and Neuland Laboratories Ltd and increased target price to Rs 875 (up 20 percent) and Rs 9100 (up 46 percent), respectively, from current market price. The brokerage house also initiated sell rating on Laurus Labs Ltd with a target price of Rs 350 a share, down 23 percent.

Goldman Sach initiates 'buy' on Syngene, Neuland, adds 'sell' tag to Larus Lab

KR Choksey recommended accumulate rating on Laurus Labs with a target price of Rs 424 in its research report dated January 29, 2024.

Accumulate Laurus Labs; target of Rs 424: KR Choksey

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 440 in its research report dated January 25, 2024.

Buy Laurus Labs; target of Rs 440: Motilal Oswal

Sharekhan recommended reduce rating on Laurus Labs with a target price of Rs 293 in its research report dated January 24, 2024.

Reduce Laurus Labs; target of Rs 293: Sharekhan

Laurus Labs Ltd. develops and manufactures active pharmaceutical ingredients for therapeutic areas of anti-retrovirals and hepatitis C. The company was founded by Dr. Satyanarayana Chava on September 19, 2005 and is headquartered in Hyderabad, India.

Watchers	3,766
52-Wk Low	299.30
52-Wk High	471.00

Volume	758,203.00
52-Wk High	471.00
52-Wk Low	299.30

LAURUSLABS.NSE Laurus Labs Ltd.

About

Feed

News

Sentiment

Fundamentals